Growth Metrics

Palisade Bio (PALI) Assets (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palisade Bio 439.25 Mn 309.68 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.77%
Dec 31, 2025 1,826.63%
Sep 30, 2025 4.59%
Jun 30, 2025 -18.60%
Mar 31, 2025 -24.72%
Dec 31, 2024 16.54%
Sep 30, 2024 -27.46%
Jun 30, 2024 1.73%
Mar 31, 2024 -9.96%
Dec 31, 2023 -17.67%
Sep 30, 2023 -6.69%
Jun 30, 2023 19.84%
Mar 31, 2023 -3.18%
Dec 31, 2022 -3.09%
Sep 30, 2022 108.38%
Jun 30, 2022 -6.51%
Mar 31, 2022 -33.26%
Dec 31, 2021 -23.12%
Sep 30, 2021 8.86%
Jun 30, 2021 67.69%
Mar 31, 2021 195.29%
Dec 31, 2020 -80.10%
Sep 30, 2020 -11.30%
Jun 30, 2020 50.54%
Mar 31, 2020 72.55%
Dec 31, 2019 -26.38%
Sep 30, 2019 153.95%
Jun 30, 2019 -34.85%
Mar 31, 2019 -29.65%
Dec 31, 2018 -0.47%
Sep 30, 2018 -16.38%
Jun 30, 2018 -20.06%
Mar 31, 2018 -16.81%
Dec 31, 2017 -14.23%
Sep 30, 2017 22.01%
Jun 30, 2017 -29.15%
Mar 31, 2017 -17.15%
Dec 31, 2016 167.49%
Sep 30, 2016 -36.44%
Jun 30, 2016 30.36%
Mar 31, 2016 -31.78%
Dec 31, 2015 -29.29%
Sep 30, 2015 -19.83%
Jun 30, 2015 -14.37%
Mar 31, 2015 3.20%
Dec 31, 2014 1.36%
Sep 30, 2014 -9.76%
Jun 30, 2014 -9.17%
Mar 31, 2014 85.05%
Dec 31, 2013 1.29%
Sep 30, 2013 38.90%
Jun 30, 2013 -10.47%
Mar 31, 2013 76.13%
Dec 31, 2012 -22.16%
Sep 30, 2012 184.08%
Jun 30, 2012 -42.20%
Mar 31, 2012 67.55%
Dec 31, 2011 -30.61%
Sep 30, 2011 -20.64%